Clinical implications of pharmacogenomics of statin treatment

被引：120
作者：
Mangravite, L. M.
Thorn, C. F.
Krauss, R. M.
机构：
[1] Childrens Hosp Oakland, Res Inst, Dept Atherosclerosis Res, Oakland, CA 94609 USA
[2] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA
来源：
PHARMACOGENOMICS JOURNAL | 2006年 / 6卷 / 06期
关键词：
D O I：
10.1038/sj.tpj.6500384
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
[No abstract available]
引用
收藏
页码：360 / 374
页数：15
相关论文
共 50 条
  • [41] Clinical implications of statin therapy in patients undergoing hemodialysis
    Kim, Jenny
    Langworthy, Diana
    Hennessey, Erin
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2014, 71 (09) : 703 - 710
  • [42] The implications of pharmacogenomics in oncology
    Latimer, Jean J.
    BIOIMPACTS, 2023, 13 (03) : 181 - 182
  • [43] Delineating significant genome-wide associations of variants with antipsychotic and antidepressant treatment response: implications for clinical pharmacogenomics
    Koromina, Maria
    Koutsilieri, Stefania
    Patrinos, George P.
    HUMAN GENOMICS, 2020, 14 (01)
  • [44] Delineating significant genome-wide associations of variants with antipsychotic and antidepressant treatment response: implications for clinical pharmacogenomics
    Maria Koromina
    Stefania Koutsilieri
    George P. Patrinos
    Human Genomics, 14
  • [45] Pharmacogenomics in the treatment of rheumatoid arthritis: Clinical implication and perspective
    Taniguchi, Atsuo
    Yamanaka, Hisashi
    Kamatani, Naoyuki
    PERSONALIZED MEDICINE, 2006, 3 (02) : 151 - 163
  • [46] CLINICAL PHARMACOGENOMICS
    Pirmohamed, Munir
    DRUG METABOLISM REVIEWS, 2014, 45 : 4 - 4
  • [47] Molecular staging and pharmacogenomics - Clinical implications: from tab to patients and back
    Franklin, WA
    Carbone, DP
    LUNG CANCER, 2003, 41 : S147 - S154
  • [48] Cardiovascular Pharmacogenomics of Adrenergic Receptor Signaling: Clinical Implications and Future Directions
    Johnson, J. A.
    Liggett, S. B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (03) : 366 - 378
  • [49] The thiopurine S-methyltransferase gene locus - implications for clinical pharmacogenomics
    McLeod, HL
    Siva, C
    PHARMACOGENOMICS, 2002, 3 (01) : 89 - 98
  • [50] Pharmacogenomics of phase II metabolizing enzymes and drug transporters: clinical implications
    Yiannakopoulou, E. Ch
    PHARMACOGENOMICS JOURNAL, 2013, 13 (02) : 105 - 109
12345